ASHP’s government affairs team is committed to representing all pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, and other components of health systems as a united voice on improving methods of medication reimbursement. 

Reimbursement Issues

• ASHP Submits Comments to CMS on HOPPS Proposed Rule [PDF]
• ASHP Proposed Statement Before the Advisory Panel on Ambulatory Payment Classification Groups [PDF]
• ASHP Submits Comments to CMS Relating to HIPPS Proposed Rule [PDF]
• Joint ASHP/SNHPA Letter to House Energy and Commerce Committee: NDC Reporting Requirement [PDF]
• Joint Letter: Coverage for Home Infusion Supplies and Services [PDF]
• Comment Letter to HHS Proposal NDC reporting requirement [PDF]
• Comment Letter: Proposed Changes to the Hospital Outpatient Prospective Payment System [PDF]
• Letter: Opposition to NDC Reporting requirement [PDF]
• Recommendations of the Advisory Panel on Ambulatory Payment Classification (APC) Groups [PDF]
• Follow-up to CMS Advisory Panel on Ambulatory Payment Classification Groups Meeting [PDF]
• Comment Letter: 340B Drug Pricing Guidelines [PDF]
• Testimony: CMS Advisory Panel on Ambulatory Payment Classification Group [PDF]
• Comment Letter: CMS Rule on NDC Numbers on Outpatient Medicaid Claims [PDF]
• Comment Letter: CMS Reimbursement Rates for Outpatient Drugs [PDF]